An early assessment of the efficacy of medicines in the treatment of patients with COVID-19
Coronavirus infection 2019 is considered a modern challenge to the world community. In the absence of vaccines and antivirals, effective and safe medicines are an urgent request from the healthcare system. We have evaluated the medical technologies for COVID-19 which are being examined. The search w...
Enregistré dans:
Auteur principal: | A. S. Kolbin |
---|---|
Format: | article |
Langue: | RU |
Publié: |
Sankt-Peterburg : NIIÈM imeni Pastera
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/01eb08e21d814ff0b0dfa1aee6ed1e0c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review
par: Alina Kröker, et autres
Publié: (2021) -
A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial
par: A. Abayomi, et autres
Publié: (2021) -
Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
par: Qomara WF, et autres
Publié: (2021) -
Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19
par: Panda PK, et autres
Publié: (2021) -
Some opportunities for immunotherapy in coronavirus infection
par: V. S. Smirnov, et autres
Publié: (2020)